ST Pharm
ST Pharm
01
Who we are
02
Our record
03
Newsroom
04
Contact
En
Ko
ST Pharm
Science & Technology
Business Overview
CDMO
Small Molecule
Oligonucleotide
mRNA
CRO
AnaPath Research & Service
R&D
Virtual R&D
Global R&D
About
ST PHARM
Key Members
History
Global Approval
ST Pharm Family
CI
Public
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Careers
ESG
Overview
Environmental
Social
Governance
Sitemap
Contact
Linkedin
Public
ST PHARM News
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
ST PHARM News
Nov 18, 2022
ST PHARM, 2022 Sustinvest ESG Rating 'AA'
- ST Pharm ranked 4th of 99 listed pharmaceutical bio companies in Korea.
- Highest grade 'AA' for 2 years.
「반출」2022_STPHARM_ESG.pdf
List